Election 2024How We SurviveOffice PoliticsI've Always Wondered ...My Economy

Loading...

0:00
0% played
Stories Tagged as

Drug prices

New class of generics could save consumers, insurers billions. FDA is moving carefully.

by Dan Gorenstein
Jul 13, 2016
The European Union has some 20 "biosimilar" generics on the market; the US has one.
Pre-filled syringes of the adalimumab biosimilar. The biosimilar is used in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis and ankylosing spondylitis.
SAM PANTHAKY/AFP/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Turns out hedge funds have an incentive to control drug prices

by Dan Gorenstein
Apr 25, 2016
Hedge funds are joining groups who want to lower prescription prices for consumers.
The local pharmacy closures have disproportionately affected rural and low-income communities.
Photo by Joe Raedle/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Valeant's story: a cautionary tale

by Dan Gorenstein
Mar 21, 2016
The company's CEO stepped down on Monday
Howard Schiller, then interim CEO of Valeant Pharmaceuticals International, Inc., listens during a hearing of the House Oversight and Government Reform Committee on Capitol Hill February 4, 2016 in Washington, DC. 
BRENDAN SMIALOWSKI/AFP/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Bad packaging means $3b in drugs will be wasted this year

by Dan Gorenstein
Mar 1, 2016
A new report suggests drug makers are profiting from the waste.
A new report suggests drug makers are profiting from the waste.
Peter Macdiarmid/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

How CVS reined in drug prices

by Sabri Ben-Achour
Feb 23, 2016
Its Caremark unit covers some 25 million U.S. customers
Spencer Platt/Getty Images
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

A push for more transparency in drug research costs

by Dan Gorenstein
Feb 16, 2016
The industry worries it's a step toward price controls.
Drug companies are not only in the spotlight for price setting, but now they may be required to be transparent about R&D spending. 
Kiran Foster/Flickr
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

How more generics could relieve sky-high drug prices

by Dan Gorenstein
Feb 4, 2016
More generics are needed to create competition — but can the FDA approve them fast enough?
With high drug prices, more generics are needed to create competition, but can the FDA is having a hard time keeping up.
NVinacco/Flickr
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

For public good, not for profit.

Donate

Survey shows drug price hikes widespread in industry

by Ashley Milne-Tyte
Feb 4, 2016
It's not just a few bad players, as Congressional hearing puts drug costs in focus.
PHILIPPE HUGUEN/AFP/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Congress turns its attention to high drug prices

by Dan Gorenstein
Jan 21, 2016
This may actually lower drug costs.
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Congress aims to give some drugmakers a break

by Dan Gorenstein
Oct 2, 2015
The push comes even as lawmakers discuss ways to rein in drug prices.
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE